Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders of pregnancy, gestational diabetes, have a preterm birth or cesarean ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Kwame Raoul is among several state AGs raising the alarm following complaints about online teleheath company Hims & Hers ...

Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people ...

At the same time, commodity prices continue to fluctuate as does demand – especially as more Americans are prescribed GLP-1 agonist drugs for weight loss and dramatically shift and reduce their ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.